# The mechanism of electrical remodeling in atrial fibrillation and current research status of natural drugs and active ingredients inhibiting atrial electrical remodeling

**Authors:** Xiangyuan Huang, Ci Wang, Yanyun Wang, Shuyu Yang, Linshan Du, Liangzhi Li, Tianyi Wang, Ying Lu

PMC · DOI: 10.3389/fcvm.2026.1705565 · Frontiers in Cardiovascular Medicine · 2026-03-11

## TL;DR

This paper reviews how natural compounds can help treat atrial fibrillation by reducing electrical changes in heart tissue.

## Contribution

The paper systematically reviews mechanisms of atrial electrical remodeling and evaluates the potential of natural drugs to inhibit this process.

## Key findings

- Atrial electrical remodeling involves gene expression changes, ion channel dysfunction, and oxidative stress.
- Natural compounds like matrine, berberine, and quercetin show potential in mitigating atrial electrical remodeling.
- These compounds offer multi-target therapeutic effects with low toxicity for managing atrial fibrillation.

## Abstract

Atrial fibrillation (AF) is the most common arrhythmia in clinical practice, with its incidence and mortality rates steadily increasing every year, posing a growing global health threat. During AF, high-frequency sustained electrical activity in atria induces electrophysiological changes. This process, known as atrial electrical remodeling (AER), in turn, plays a crucial role in both the initiation and maintenance of AF. Key contributors to AER include abnormalities in gene expression, alterations in electrophysiology, dysfunction of the ion channel, inflammatory responses, and oxidative stress. Natural compounds, primarily derived from plants and other natural resources, have attracted considerable attention for their high efficacy, low toxicity, and ability to target multiple therapeutic pathways. These compounds—such as matrine, berberine, ginsenosides, quercetin, icariin, and tanshinone—offer comprehensive regulatory effects that can effectively attenuate AER, providing unique therapeutic advantages in the management of AF. This review systematically synthesizes the mechanisms underlying AER and examines how natural drugs and their active ingredients can mitigate AF by inhibiting this remodeling process, offering valuable insights for the development of potentially effective natural therapeutics against AF.

Circular diagram illustrating mechanisms of myocardial remodeling, showing how inflammatory response, oxidative stress, autonomic nerve, and MicroRNA contribute to changes in cardiac electrophysiology and ion channels, leading to both electrical and structural heart remodeling.

## Linked entities

- **Chemicals:** matrine (PubChem CID 91466), berberine (PubChem CID 2353), ginsenosides (PubChem CID 3086007), quercetin (PubChem CID 5280343), icariin (PubChem CID 5318997), tanshinone (PubChem CID 114917)
- **Diseases:** atrial fibrillation (MONDO:0004981)

## Full-text entities

- **Diseases:** toxicity (MESH:D064420), arrhythmia (MESH:D001145), inflammatory (MESH:D007249), AF (MESH:D001281)
- **Chemicals:** berberine (MESH:D001599), ginsenosides (MESH:D036145), tanshinone (MESH:C021751), quercetin (MESH:D011794), icariin (MESH:C056599), matrine (MESH:D000093842)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13012934/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13012934/full.md

## References

368 references — full list in the complete paper: https://tomesphere.com/paper/PMC13012934/full.md

---
Source: https://tomesphere.com/paper/PMC13012934